• Enriched CAR-T Shows Durable Responses in Multiple Myeloma

    3 days ago - By MedPageToday

    An enriched chimeric antigen receptor T-cell therapy called bb21217 improved responses and prolonged duration of response compared with non-enriched CAR T cells in patients with relapsed/refractory multiple myeloma, according...
    Read more ...

     

  • CAR T-cell Products Shine, Reveal New Insights

    CAR T-cell Products Shine, Reveal New Insights

    3 days ago - By Medscape

    The 12-month response and progression-free survival rates in 152 real-world patients treated with tisagenlecleucel for an approved indication were 48.4% and 26.4%, respectively.
    Medscape Medical News
    Read more ...

     

  • Novel ddPCR Assay Precisely Measures CAR T-cells After Infusion

    3 days ago - By Medscape

    A novel quantitative assay used with flow cytometry precisely measures CAR T-cell engraftment and in vivo expansion to predict patient outcomes after CAR T-cell infusion, according to researchers.
    Medscape Medical News
    Read more ...